148 related articles for article (PubMed ID: 32358972)
1. Epidemiological profile and severity of erythema nodosum leprosum in Brazil: a cross-sectional study.
Baima de Melo C; Silva de Sá BD; Aníbal Carvalho Costa F; Nunes Sarno E
Int J Dermatol; 2020 Jul; 59(7):856-861. PubMed ID: 32358972
[TBL] [Abstract][Full Text] [Related]
2. ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum.
Walker SL; Balagon M; Darlong J; Doni SN; Hagge DA; Halwai V; John A; Lambert SM; Maghanoy A; Nery JA; Neupane KD; Nicholls PG; Pai VV; Parajuli P; Sales AM; Sarno E; Shah M; Tsegaye D; Lockwood DN;
PLoS Negl Trop Dis; 2015; 9(9):e0004065. PubMed ID: 26351858
[TBL] [Abstract][Full Text] [Related]
3. A leprosy clinical severity scale for erythema nodosum leprosum: An international, multicentre validation study of the ENLIST ENL Severity Scale.
Walker SL; Sales AM; Butlin CR; Shah M; Maghanoy A; Lambert SM; Darlong J; Rozario BJ; Pai VV; Balagon M; Doni SN; Hagge DA; Nery JAC; Neupane KD; Baral S; Sangma BA; Alembo DT; Yetaye AM; Hassan BA; Shelemo MB; Nicholls PG; Lockwood DNJ;
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005716. PubMed ID: 28671966
[TBL] [Abstract][Full Text] [Related]
4. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of the severe and uncommon variants of erythema nodosum leprosum at a tertiary health center in central India.
Wankhade VH; Debnath P; Singh RP; Sawatkar G; Bhat DM
Int J Mycobacteriol; 2019; 8(1):29-34. PubMed ID: 30860176
[TBL] [Abstract][Full Text] [Related]
6. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia.
Negera E; Walker SL; Girma S; Doni SN; Tsegaye D; Lambert SM; Idriss MH; Tsegay Y; Dockrell HM; Aseffa A; Lockwood DN
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006011. PubMed ID: 29028793
[TBL] [Abstract][Full Text] [Related]
7. A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction.
Voorend CG; Post EB
PLoS Negl Trop Dis; 2013; 7(10):e2440. PubMed ID: 24098819
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for erythema nodosum leprosum.
Manandhar R; LeMaster JW; Roche PW
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
[TBL] [Abstract][Full Text] [Related]
9. The mortality associated with erythema nodosum leprosum in Ethiopia: a retrospective hospital-based study.
Walker SL; Lebas E; Doni SN; Lockwood DN; Lambert SM
PLoS Negl Trop Dis; 2014 Mar; 8(3):e2690. PubMed ID: 24625394
[TBL] [Abstract][Full Text] [Related]
10. Histopathological study of ocular erythema nodosum leprosum and post-therapeutic scleral perforation: a case report.
Rathinam SR; Khazaei HM; Job CK
Indian J Ophthalmol; 2008; 56(5):417-9. PubMed ID: 18711273
[TBL] [Abstract][Full Text] [Related]
11. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
[TBL] [Abstract][Full Text] [Related]
12. International workshop on erythema nodosum leprosum (ENL)--consensus report; the formation of ENLIST, the ENL international study group.
Walker SL; Saunderson P; Kahawita IP; Lockwood DN
Lepr Rev; 2012 Dec; 83(4):396-407. PubMed ID: 23614260
[No Abstract] [Full Text] [Related]
13. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.
Negera E; Tilahun M; Bobosha K; Lambert SM; Walker SL; Spencer JS; Aseffa A; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714
[TBL] [Abstract][Full Text] [Related]
14. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
Balagon M; Saunderson PR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
[TBL] [Abstract][Full Text] [Related]
15. Erythema nodosum leprosum on glans penis: unusual manifestation of common disease.
Kothiwala SK; Khandpur S; Singh MK; Durgapal P
Int J Dermatol; 2015 Sep; 54(9):1060-3. PubMed ID: 25557912
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
Front Immunol; 2018; 9():189. PubMed ID: 29479352
[TBL] [Abstract][Full Text] [Related]
17. Toxoplasma gondii infection and high levels of IgE are associated to erythema nodosum leprosy (ENL).
Nascimento LS; de Castro YS; Figueira JA; Souza RDC; da Silva JA; Nahn EP; Peixoto-Rangel AL
PLoS One; 2024; 19(6):e0300704. PubMed ID: 38865430
[TBL] [Abstract][Full Text] [Related]
18. [Erythema nodosum leprosum case series report: clinical profile, immunological basis and treatment implemented in health services].
Guerra JG; Penna GO; Castro LC; Martelli CM; Stefani MM; Costa MB
Rev Soc Bras Med Trop; 2004; 37(5):384-90. PubMed ID: 15361954
[TBL] [Abstract][Full Text] [Related]
19. Household costs of leprosy reactions (ENL) in rural India.
Chandler DJ; Hansen KS; Mahato B; Darlong J; John A; Lockwood DN
PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003431. PubMed ID: 25590638
[TBL] [Abstract][Full Text] [Related]
20. Erythema nodosum leprosum presenting as sweet's syndrome-like reaction in a borderline lepromatous leprosy patient.
Suryawati N; Saputra H
Int J Mycobacteriol; 2018; 7(2):191-194. PubMed ID: 29900900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
